Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
An occupational lung disorder caused by inhalation of dust particles. It is characterized by bilateral interstitial lung infiltrates. Representative examples include asbestosis, silicosis, anthracosis, and talc pneumoconiosis.
Biomarker and diagnostic research for pneumoconiosis has been reported in the published literature.
5 clinical trials registered, 2 recruiting. Interventions under study include drug therapy, other interventions, and procedural interventions. Pipeline includes 1 PHASE3, 1 PHASE2, 1 EARLY_PHASE1. Research is sponsored by a mix of industry and academic institutions.
NCT ID | Title | Phase | Sponsor | Status |
|---|---|---|---|---|
[NCT07077382](https://clinicaltrials.gov/study/NCT07077382) |
Data assembled from 4 of 12 sources · Last updated Sep 19, 2026, 11:53 AM UTC
European rare disease database
Genetic and Rare Diseases Info Center
Pneumoconiosis and Dust Exposure China Cohort |
— |
China-Japan Friendship Hospital |
RECRUITING |
[NCT07178184](https://clinicaltrials.gov/study/NCT07178184) | Evaluating the Efficacy and Safety of Modified Qing-Zao-Jiu-Fei Decoction on Pneumoconiosis Patients | PHASE2 | Chinese University of Hong Kong | NOT_YET_RECRUITING |
[NCT05288179](https://clinicaltrials.gov/study/NCT05288179) | Efficacy and Safety of Pirfenidone Capsules in the Treatment of Pneumoconiosis | PHASE3 | Beijing Continent Pharmaceutical Co, Ltd. | RECRUITING |
[NCT06563674](https://clinicaltrials.gov/study/NCT06563674) | Acceptance-based Healthy Lifestyles Program for Patients With Pneumoconiosis | NA | Chinese University of Hong Kong | UNKNOWN |
[NCT05365802](https://clinicaltrials.gov/study/NCT05365802) | FAPI PET for Lung Fibrosis | EARLY_PHASE1 | University of California, Los Angeles | ACTIVE_NOT_RECRUITING |
344 publications have been identified in PubMed for pneumoconiosis. Kisho has analyzed 128 by research type. Research spans Epidemiology / Natural History (36%), Review / Meta-Analysis (25%), and Basic Science / Preclinical (16%).
Research Type | Count | % of Total |
|---|---|---|
Disease patterns and progression | 46 | 36% |
Research summaries | 32 | 25% |
Laboratory research | 20 | 16% |
Testing and diagnosis research | 16 | 13% |
Patient case studies | 9 | 7% |
New treatment approaches | 3 | 2% |
Other research | 1 | 1% |
Clinical study results | 1 | 1% |
Hu E (2026). [PMID: 41763510](https://pubmed.ncbi.nlm.nih.gov/41763510/). *Chem Biol Interact*. [Basic Science / Preclinical]
Baum L (2026). [PMID: 37603636](https://pubmed.ncbi.nlm.nih.gov/37603636/). *Unknown Journal*. [Diagnostic / Biomarker]
He X (2026). [PMID: 42211572](https://pubmed.ncbi.nlm.nih.gov/42211572/). *Front Cell Dev Biol*. [Review / Meta-Analysis]
Dubey S (2026). [PMID: 41921044](https://pubmed.ncbi.nlm.nih.gov/41921044/). *Physiol Rev*. [Review / Meta-Analysis]
Yang F (2026). [PMID: 41800803](https://pubmed.ncbi.nlm.nih.gov/41800803/). *Animal Model Exp Med*. [Diagnostic / Biomarker]
Oh J (2026). [PMID: 41495401](https://pubmed.ncbi.nlm.nih.gov/41495401/). *Nature medicine*. [Epidemiology / Natural History]
Chen YY (2026). [PMID: 41247264](https://pubmed.ncbi.nlm.nih.gov/41247264/). *J Occup Environ Med*. [Basic Science / Preclinical]
Zhong YF (2026). [PMID: 41795808](https://pubmed.ncbi.nlm.nih.gov/41795808/). *J Int Med Res*. [Case Report / Case Series]
Tian Y (2026). [PMID: 42141418](https://pubmed.ncbi.nlm.nih.gov/42141418/). *Clin Proteomics*. [Diagnostic / Biomarker]
Wang L (2026). [PMID: 41566645](https://pubmed.ncbi.nlm.nih.gov/41566645/). *Adv Sci (Weinh)*. [Basic Science / Preclinical]
AI-curated news mentioning pneumoconiosis
Updated Sep 12, 2026
A recent study evaluates lung transplant outcomes for patients with coal workers' pneumoconiosis, comparing them to national outcomes for non-occupational interstitial lung disease. This research highlights the unique challenges faced by coal miners in transplant settings.
A recent case report highlights Caplan's syndrome, a rare form of pneumoconiosis, emphasizing its clinical presentation and implications for diagnosis. This study contributes to the understanding of this rare disease and its management in clinical practice.